Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Clinuvel Pharmaceuticals Ltd ADR (CLVLY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
9.974 +0.174    +1.78%
20:41:00 - Closed. Currency in USD ( Disclaimer )
  • Volume: 514
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 9.974 - 9.974
Type:  Equity
Market:  United States
Clinuvel Pharmaceuticals ADR 9.974 +0.174 +1.78%

Clinuvel Pharmaceuticals ADR Company Profile

 
Read the Clinuvel Pharmaceuticals Ltd ADR company profile to learn more about the business and the management team. View Clinuvel Pharmaceuticals Ltd DRC facts about employee data, company products and services, and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

-

Equity Type

ADR

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company’s pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), which provoke prolonged cellular activity; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. The company was founded in 1987 and is headquartered in Melbourne, Australia.

Contact Information

Address 535 Bourke Street Level 22
Melbourne, 3000
Australia
Phone 61 3 9660 4900
Fax 61 3 9660 4909

Top Executives

Name Age Since Title
Brenda Mary Shanahan - 2007 Non-Executive Director
Philippe Jacques Wolgen 60 2005 CEO, MD & Director
Jeffrey V. Rosenfeld - 2019 Non-Executive Chairman
Susan E. Smith - 2019 Non-Executive Director
Karen A. Agersborg - 2018 Non-Executive Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CLVLY Price Commentary

Write your thoughts about Clinuvel Pharmaceuticals Ltd ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ben Schoning
Ben Schoning Sep 17, 2020 10:38
Saved. See Saved Items.
This comment has already been saved in your Saved Items
CUV is a strong buy , one of the best and safest investments you can probably find during the pandemic
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email